Neuroendocrine Cell Signaling in Prostate Cancer
前列腺癌中的神经内分泌细胞信号转导
基本信息
- 批准号:6563900
- 负责人:
- 金额:$ 19.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-02-01 至 2003-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This proposal focuses on neuroendocrine (NE) cells of the prostate and the role they play in promoting androgen-interdependent growth of prostate tumors. Neuroendocrine (NE) cells are fully differentiated, post- mitotic secretory cells that populate both normal and malignant prostate tissue. Morphologically, NE cells can be identified by their characteristic neuronal appearance, which includes the presence of long neuritic processes and dense secretory vesicles in the cell body. In prostate tumors the proliferative index of neoplastic epithelial cells surrounding the NE cells is also frequently elevated, suggesting that the NE cells act in a paracrine fashion by secreting growth-inducing factors and contributing toe the progression of the disease. Several of these factors have been identified and include serotonin, thyroid stimulating hormone (TSH), calcitonin, bombesin, and somatostatin. Increases in the number of NE cells occur as part of tumor progression, presumably. Increases in the number of NE cells occur as part of tumor progression, presumably due to the influence of both genetic and epigenetic factors. The origin of these increased number sin later stage prostatic carcinomas is uncertain, but several studies suggest that NE cells arise from within the tumor, either from a hyperplastic basal epithelial cell or from a transformed exocrine epithelial c4ll by de-differentiation or trans-differentiation, respectively. Bang have in fact shown that the prostate tumor cells, LNCaP and PC3M, can be induced to differentiate into post-mitotic NE-like cells upon addition for agents that increase intracellular cyclic AMP. These experiments provide evidence for the transdifferentiation model of NE cell derivation and suggest that physiological factors that elevate internal cAMP levels may play a role in the differentiation process. The goal of the studies described in this proposal is to identify physiological factors and critical signaling pathways that contribute to the differentiation of NE cells and to determine whether NE cells secrete paracrine signals which potential the growth of prostate carcinomas. To accomplish these aims, a panel of hormones and peptide factors that cause elevations in intracellular cAMP in LNCaP cells will be tested, and signaling pathways emanating from the most potent differentiating agents will be analyzed. In addition, a LacSwitch will be generated that directs the regulated expression of a constitutively active form of the catalytic subunit of protein kinase I and used to differentiated prostate tumor cell lines to NE cells. These differentiated cells will then be tested both in culture and in the animal for their ability to enhance proliferation of non-differentiated tumor cells. Finally, the signaling mechanisms regulating secretion will also be examined. The goals of the project are to elucidate signaling pathways that regulate differentiation and secretion of cell cells and to identify critical components of these pathways that could serve as molecular targets for the development of novel therapies for late stage, androgen-independent prostate tumors.
该提案重点关注前列腺的神经内分泌(NE)细胞及其在促进前列腺肿瘤雄激素依赖性生长中所发挥的作用。神经内分泌(NE)细胞是完全分化的有丝分裂后分泌细胞,存在于正常和恶性前列腺组织中。 在形态学上,NE细胞可以通过其特征性神经元外观来识别,其中包括细胞体内存在长的神经突和致密的分泌囊泡。在前列腺肿瘤中,NE细胞周围的肿瘤上皮细胞的增殖指数也经常升高,这表明NE细胞通过分泌生长诱导因子以旁分泌方式发挥作用并促进疾病的进展。其中一些因素已被确定,包括血清素、促甲状腺激素 (TSH)、降钙素、铃蟾肽和生长抑素。 NE 细胞数量的增加可能是肿瘤进展的一部分。 NE 细胞数量的增加是肿瘤进展的一部分,可能是由于遗传和表观遗传因素的影响。晚期前列腺癌中这些数量增加的起源尚不清楚,但一些研究表明,NE 细胞来自肿瘤内部,要么来自增生性基底上皮细胞,要么来自通过去分化或转分化转化的外分泌上皮细胞。分别。 Bang 事实上表明,在添加增加细胞内环 AMP 的药物后,前列腺肿瘤细胞 LNCaP 和 PC3M 可以被诱导分化为有丝分裂后 NE 样细胞。这些实验为 NE 细胞衍生的转分化模型提供了证据,并表明提高内部 cAMP 水平的生理因素可能在分化过程中发挥作用。本提案中描述的研究目标是确定有助于 NE 细胞分化的生理因素和关键信号通路,并确定 NE 细胞是否分泌可能促进前列腺癌生长的旁分泌信号。为了实现这些目标,将测试一组导致 LNCaP 细胞中胞内 cAMP 升高的激素和肽因子,并分析来自最有效的分化剂的信号传导途径。此外,还将生成一个 LacSwitch,它指导蛋白激酶 I 催化亚基的组成型活性形式的调节表达,并用于将前列腺肿瘤细胞系分化为 NE 细胞。然后将在培养物和动物体内测试这些分化细胞增强非分化肿瘤细胞增殖的能力。 最后,还将检查调节分泌的信号机制。该项目的目标是阐明调节细胞分化和分泌的信号通路,并确定这些通路的关键组成部分,这些组成部分可以作为开发晚期、雄激素非依赖性前列腺肿瘤新疗法的分子靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SARAH J PARSONS其他文献
SARAH J PARSONS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SARAH J PARSONS', 18)}}的其他基金
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
- 批准号:
7135324 - 财政年份:2006
- 资助金额:
$ 19.9万 - 项目类别:
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
- 批准号:
7428876 - 财政年份:2006
- 资助金额:
$ 19.9万 - 项目类别:
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
- 批准号:
7629190 - 财政年份:2006
- 资助金额:
$ 19.9万 - 项目类别:
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
- 批准号:
7826710 - 财政年份:2006
- 资助金额:
$ 19.9万 - 项目类别:
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
- 批准号:
7254940 - 财政年份:2006
- 资助金额:
$ 19.9万 - 项目类别:
c Src and EGF Receptor in Breast Cancer Development
c Src 和 EGF 受体在乳腺癌发展中的作用
- 批准号:
6690649 - 财政年份:2003
- 资助金额:
$ 19.9万 - 项目类别:
FUNCTION OF C-SRC AND RELATED KINASES IN CHROMAFFIN CELLS
C-SRC 及相关激酶在嗜铬细胞中的功能
- 批准号:
6311495 - 财政年份:2000
- 资助金额:
$ 19.9万 - 项目类别:
相似海外基金
The Role of p73 in Upper Gastrointestinal Carcinomas
p73 在上消化道癌中的作用
- 批准号:
7046787 - 财政年份:2006
- 资助金额:
$ 19.9万 - 项目类别:
Retinoids, RAMBAs, and Histone Deacetylase Inhibitors
类维生素A、RAMBA 和组蛋白脱乙酰酶抑制剂
- 批准号:
7140176 - 财政年份:2005
- 资助金额:
$ 19.9万 - 项目类别:
Retinoids, RAMBAs, and Histone Deacetylase Inhibitors
类维生素A、RAMBA 和组蛋白脱乙酰酶抑制剂
- 批准号:
6963335 - 财政年份:2005
- 资助金额:
$ 19.9万 - 项目类别:
The Role of p73 in Upper Gastrointestinal Carcinomas
p73 在上消化道癌中的作用
- 批准号:
6921826 - 财政年份:2005
- 资助金额:
$ 19.9万 - 项目类别: